Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elevation Oncology
Biotech
Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal
Elevation Oncology has agreed to pay Synaffix up to $368 million to access technology for use in its newly nominated HER3 antibody-drug conjugate.
Nick Paul Taylor
Dec 12, 2024 9:19am
Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders
Jul 14, 2023 9:30am
Century, Elevation to cut assets, staff; Nabriva winds down
Jan 6, 2023 10:40am
Elevation Oncology sets out for clinic climb in $27M ADC deal
Jul 28, 2022 11:37am
Qiming Venture Partners raises $260M, adds biotech CEO partner
Jun 3, 2022 12:08pm
Elevation files for $100M IPO to fund tumor-agnostic candidate
Jun 7, 2021 8:05am
